Clinical Trial Update: Efficacy of SNX-1012 in the Treatment of Oral Mucositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SNX-1012 for oral mucositis/stomatitis has completed enrollment and posted results in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Mucositis
• Stomatitis

Drugs mentioned

• SNX-1012

Snippet

Sponsor: Mucosal Therapeutics | Conditions: Stomatitis, Oral Mucositis | Phase 2 | Status: COMPLETED | Results posted: 2009-03-18